Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Clinical trial NCT02041468 · UNKNOWN

Trial details

NCT number: NCT02041468
Sponsor: Jewish General Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2014-01-01
Primary completion: 2018-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.